<VariationArchive VariationID="2500753" VariationName="NM_004491.5(ARHGAP35):c.2814dup (p.Lys939Ter)" VariationType="Duplication" Accession="VCV002500753" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2023-05-07" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2523651" VariationID="2500753">
      <GeneList>
        <Gene Symbol="ARHGAP35" FullName="Rho GTPase activating protein 35" GeneID="2909" HGNC_ID="HGNC:4591" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46860997" stop="47005077" display_start="46860997" display_stop="47005077" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47421932" stop="47508333" display_start="47421932" display_stop="47508333" Strand="+" />
          </Location>
          <OMIM>605277</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004491.5(ARHGAP35):c.2814dup (p.Lys939Ter)</Name>
      <CanonicalSPDI>NC_000019.10:46921483:TTTTTT:TTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="46921483" stop="46921484" display_start="46921483" display_stop="46921484" variantLength="1" positionVCF="46921483" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="47424740" stop="47424741" display_start="47424740" display_stop="47424741" variantLength="1" positionVCF="47424740" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>K939*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.46921489dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.46921489dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.47424746dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.47424746dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_047014.2" sequenceAccession="NG_047014" sequenceVersion="2" change="g.65493dup">
            <Expression>NG_047014.2:g.65493dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004491.5" sequenceAccession="NM_004491" sequenceVersion="5" change="c.2814dup" MANESelect="true">
            <Expression>NM_004491.5:c.2814dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004482.4" sequenceAccession="NP_004482" sequenceVersion="4" change="p.Lys939Ter">
            <Expression>NP_004482.4:p.Lys939Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004491.5(ARHGAP35):c.2814dup (p.Lys939Ter) AND Neurodevelopmental disorder" Accession="RCV003225665" Version="2">
        <ClassifiedConditionList TraitSetID="37229">
          <ClassifiedCondition DB="MedGen" ID="C1535926">Neurodevelopmental disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-05-07" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">33057194</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="37229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38088" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder</ElementValue>
                <XRef ID="MONDO:0700092" DB="MONDO" />
              </Name>
              <XRef ID="C1535926" DB="MedGen" />
              <XRef ID="D065886" DB="MeSH" />
              <XRef ID="MONDO:0700092" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7331280" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_004491_4_ARHGAP35_c_2814dupT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003921912" DateUpdated="2024-07-23" DateCreated="2023-05-06" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33057194</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with neurodevelopmental disorder, ARHGAP35-related (MONDO#0700092). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0703 - Other NMD-predicted variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. At least four other NMD-predicted variants have been reported de novo in individuals with developmental delay (PMID: 33057194). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARHGAP35" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13736</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004491.4:c.2814dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0700092" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13026601</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7331280" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0700092" MappingRef="MONDO">
        <MedGen CUI="C1535926" Name="Neurodevelopmental disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

